BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31828431)

  • 1. What's new in fibroblastic tumors?
    Armstrong SM; Demicco EG
    Virchows Arch; 2020 Jan; 476(1):41-55. PubMed ID: 31828431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel EWSR1-SMAD3 Gene Fusions in a Group of Acral Fibroblastic Spindle Cell Neoplasms.
    Kao YC; Flucke U; Eijkelenboom A; Zhang L; Sung YS; Suurmeijer AJH; Antonescu CR
    Am J Surg Pathol; 2018 Apr; 42(4):522-528. PubMed ID: 29309308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.
    Michal M; Berry RS; Rubin BP; Kilpatrick SE; Agaimy A; Kazakov DV; Steiner P; Ptakova N; Martinek P; Hadravsky L; Michalova K; Szep Z; Michal M
    Am J Surg Pathol; 2018 Oct; 42(10):1325-1333. PubMed ID: 29957732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric fibroblastic and myofibroblastic lesions.
    Thway K; Fisher C; Sebire NJ
    Adv Anat Pathol; 2012 Jan; 19(1):54-65. PubMed ID: 22156834
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Foot O; Hallin M; Jones RL; Sumathi VP; Thway K
    Int J Surg Pathol; 2021 Apr; 29(2):179-181. PubMed ID: 32615834
    [No Abstract]   [Full Text] [Related]  

  • 6. Superficial CD34-Positive Fibroblastic Tumor.
    Foot O; Hallin M; Bagué S; Jones RL; Thway K
    Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis].
    Su HY; Zhao L; Ji G; Yao QL; Bai QM; Zhou XY; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):19-24. PubMed ID: 36617901
    [No Abstract]   [Full Text] [Related]  

  • 8. EWSR1-SMAD3 rearranged fibroblastic tumor: Case series and review.
    Habeeb O; Korty KE; Azzato EM; Astbury C; Farkas DH; Ko JS; Billings SD
    J Cutan Pathol; 2021 Feb; 48(2):255-262. PubMed ID: 32901982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibroblastic and myofibroblastic tumors of the head and neck].
    Saïji E; Guillou L
    Ann Pathol; 2009 Sep; 29(4):335-46. PubMed ID: 19900638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblastic and myofibroblastic tumors of the head and neck: comprehensive imaging-based review with pathologic correlation.
    Hourani R; Taslakian B; Shabb NS; Nassar L; Hourani MH; Moukarbel R; Sabri A; Rizk T
    Eur J Radiol; 2015 Feb; 84(2):250-60. PubMed ID: 25467227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.
    Baranov E; Hornick JL
    Head Neck Pathol; 2020 Mar; 14(1):43-58. PubMed ID: 31950474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of pediatric fibroblastic and myofibroblastic tumors.
    Hicks J; Mierau G
    Ultrastruct Pathol; 2004; 28(5-6):265-81. PubMed ID: 15764576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial CD34-positive fibroblastic tumor: Cytologic features, tissue correlation, ancillary studies, and differential diagnosis of a recently described soft tissue neoplasm.
    Li W; Molnar SL; Mott M; White E; De Las Casas LE
    Diagn Cytopathol; 2016 Nov; 44(11):926-930. PubMed ID: 27432164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
    Bruce-Brand C; Conradie W; Schneider JW
    Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Fibroblastic and Myofibroblastic Tumors: A Pictorial Review.
    Sargar KM; Sheybani EF; Shenoy A; Aranake-Chrisinger J; Khanna G
    Radiographics; 2016; 36(4):1195-214. PubMed ID: 27399243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing.
    Parham DM
    F1000Res; 2018; 7():. PubMed ID: 30613391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
    Johnson C; Parsa L; Gibbs J; Sligh J
    J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
    Georgantzoglou N; Linos K
    Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWSR1-SMAD3 positive fibroblastic tumor.
    Zhao L; Sun M; Lao IW; Yu L; Wang J
    Exp Mol Pathol; 2019 Oct; 110():104291. PubMed ID: 31376366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.